Caricamento...
Pharmacological activation of wild-type p53 in the therapy of leukemia
The tumor suppressor p53 is inactivated by mutations in a majority of human solid tumors. Conversely, in leukemias p53 mutations are rare since they are only observed in a small fraction of the patient population, predominately in patients with complex karyotype acute myeloid leukemia or hypodiploid...
Salvato in:
| Pubblicato in: | Exp Hematol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5062953/ https://ncbi.nlm.nih.gov/pubmed/27327543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2016.05.014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|